Showing all 3 results
Divalproex Sodium Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the intensely hygroscopic active ingredient.
Active Ingredient Strength Primary Clinical Function Divalproex Sodium USP/Ph.Eur. 250 mg (DR / ER) The Titration & Pediatric Standard: The definitive unit utilized for careful initial dose titration in adult bipolar patients or weight-based dosing for pediatric epilepsy. Divalproex Sodium USP/Ph.Eur. 500 mg (DR / ER) The Neurology Macrodose: Massive therapeutic payload utilized for the aggressive, sustained suppression of chronic complex partial seizures and acute bipolar mania. Excipients (Enteric DR Formulation) Microcrystalline Cellulose / Croscarmellose Sodium / Povidone / Methacrylic Acid Copolymer (Eudragit) / Triethyl Citrate / Titanium Dioxide Diluent / Superdisintegrant / Binder / Enteric Polymer / Plasticizer / Opaque Film (Engineered specifically utilizing advanced fluid-bed enteric coating to completely shield the highly corrosive valproate compound from the stomach, ensuring the pill only dissolves in the alkaline environment of the small intestine to prevent severe gastric bleeding and vomiting) *Pack Sizes: 10×10 Alu-Alu Blisters or Heavy-Gauge HDPE Bottles (Optimized specifically for strict chronic neurology and psychiatry dispensing regimens).
Lithium Carbonate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute physical stability of the controlled-release polymers.
Active Ingredient Strength Primary Clinical Function Lithium Carbonate USP/Ph.Eur. 300 mg (IR) Acute Mania Standard: Immediate-release base unit used for the rapid, aggressive titration of serum lithium levels during an active, severe manic episode. Lithium Carbonate USP/Ph.Eur. 400 mg / 450 mg (ER/SR) Global Maintenance Standard: Extended-release therapy designed to flatten the pharmacokinetic curve, preventing toxic blood spikes and minimizing severe hand tremors and nausea during lifelong maintenance therapy. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Sodium Starch Glycolate / Magnesium Stearate / Premium Opadry Film Hydrophilic ER Polymer / Diluent / Disintegrant / Lubricant (Engineered specifically using high-shear wet granulation to form a highly reliable, slow-eroding matrix that trickles the elemental lithium into the bloodstream over 12 hours) *Pack Sizes: Bottles of 100 or 10×10 Blisters (Optimized specifically for strict, massive-volume lifelong psychiatric dispensing regimens).
Oxcarbazepine Tablet
FreeProduct Composition & Available Strengths
We manufacture Oxcarbazepine in the full, internationally standardized range of strengths to allow for the precise, progressive dose titration mandatory in anti-epileptic therapy.
Active Ingredient Available Strengths Primary Clinical Target Oxcarbazepine IP / BP / USP 150 mg Pediatric & Initial Titration: For low-dose introductory phases to assess patient tolerance. Oxcarbazepine IP / BP / USP 300 mg Standard Maintenance: The foundational daily maintenance dose for adolescent and adult stabilization. Oxcarbazepine IP / BP / USP 600 mg High-Potency Control: For refractory focal seizures or high-threshold therapeutic stabilization.
